Icu Medical Stock News

Does ICU Medical (ICUI) have what it takes to be a top stock pick for momentum investors? Let's find out.

ICU Medical (ICUI) possesses solid growth attributes, which could help it handily outperform the market.

SAN FRANCISCO , March 11, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Central Venous Catheters (CVCs) - Global Market Trajectory & Analytics" . The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace. FACTS AT A GLANCE What''s New for 2022? Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-peer collaborative bespoke updates Access to our digital archives and MarketGlass Research Platform Complimentary updates for one year Edition: 7; Released: February 2022 Executive Pool: 4019 Companies: 61 - Players covered include Amecath; AngioDynamics Inc.; B. Braun Melsungen AG; Bactiguard AB; Becton, Dickinson and Company; COOK MEDICAL LLC; Edwards Lifesciences Corporation; Guangdong Baihe Medical Technology Co., Ltd; ICU Medical, Inc.; Insung Medical Co.

New York, USA, March 09, 2022 (GLOBE NEWSWIRE) -- The Global Peripherally Inserted Central Catheters (PICC) Market To Progress At A CAGR of 5.23% During The Study Period (2018-26) As per DelveInsight analysis, the Peripherally Inserted Central Catheters market size is increasing owing to the factors such as rising incidence of cancer, infectious diseases, growing demand for PICC, integration of advanced technologies to the existing products, new product launches by leading players, among others. DelveInsight''s Peripherally Inserted Central Catheters Market Insights report provides the current and forecast market, upcoming device innovation, individual leading companies market shares, challenges, market drivers, barriers, and trends, and key Peripherally Inserted Central Catheters companies in the market. Key Takeaways from the Global Peripherally Inserted Central Catheters Market According to DelveInsight analysis, North America is anticipated to dominate the global Peripherally Inserted Central Catheters market during the forecast period.

ICU Medical (ICUI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

SAN CLEMENTE, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Raymond James 43 r d Annual Institutional Investors Conference at 11:15 a.m. PT (2:15 p.m. ET) on Tuesday, March 8, 2022.

ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q4 2021 Results - Earnings Call Transcript

ICU Medical press release (NASDAQ:ICUI): Q4 Non-GAAP EPS of $1.82 beats by $0.18.Revenue of $340.53M (+6.3% Y/Y) beats by $16.63M.Shares -0.31%.

ICU Medical (ICUI) delivered earnings and revenue surprises of 11.66% and 6.30%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Chemotherapy Devices Market finds that increasing prevalence of cancer is expediting market growth. Primarily driven by increasing cardiovascular surgeries and diagnostics, the total Global Chemotherapy Devices Market is estimated to reach USD 23.12 Billion by 2028 . The Market stood at a revenue of USD 11.54 Billion in the year 2021, and is expected to exhibit a Compound Annual Growth Rate (CAGR) of 7.5%. Furthermore, the increase in technological advancements is also anticipated to augment the growth of the Global Chemotherapy Devices Market, states Vantage Market Research, in a report, titled " Chemotherapy Devices Market by Product (Catheter, Cannula, Pump, Others), by Application (Hospital, Clinics, Home Care), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)". Click Here To Access The Free Sample Report @ https://www.vantagemarketresearch.com/chemotherapy-devices-market-1310/request-sample (The Free Sample Of This Report Is Readily Available On Request).

The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file by the SEC.

SAN CLEMENTE, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of i